The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities

Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast rang...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2021-04, Vol.64 (7), p.3508-3545
Hauptverfasser: Robello, Marco, Barresi, Elisabetta, Baglini, Emma, Salerno, Silvia, Taliani, Sabrina, Settimo, Federico Da
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3545
container_issue 7
container_start_page 3508
container_title Journal of medicinal chemistry
container_volume 64
creator Robello, Marco
Barresi, Elisabetta
Baglini, Emma
Salerno, Silvia
Taliani, Sabrina
Settimo, Federico Da
description Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast range of biological targets, thus presenting clinical potential for a plethora of pathological conditions. The purpose of this perspective is to provide insights into the versatility of this chemical moiety as a privileged structure in drug discovery. After a brief analysis of its physical–chemical features and synthetic procedures to obtain it, α-ketoamide-based classes of compounds are reported according to the application of this motif as either a nonreactive or reactive moiety. The goal is to highlight those aspects that may be useful to understanding the perspectives of employing the α-ketoamide moiety in the rational design of compounds able to interact with a specific target.
doi_str_mv 10.1021/acs.jmedchem.0c01808
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8154582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2505361317</sourcerecordid><originalsourceid>FETCH-LOGICAL-a515t-7ac2884f7d7575363bcddb48b6f5565f252b8a1c6121535589de67d0f29491e23</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EotPCGyDkJZsM_okTDwuk0aiUilZlUdaWY98krhIn2E6left6mGkFG1aW7HPOPb4fQh8oWVPC6Gdt4vphBGt6GNfEECqJfIVWVDBSlJKUr9GKEMYKVjF-hs5jfCCEcMr4W3TGeV2VpBIrtNz3gLfD3Gv8A9KEt6OzgG8nB2mPdcQa_wzu0Q3Qgc3XybXYeXwL1hnn9YB3ebqLKey_4N0SAviEr310XZ-y11t8OULonO_w3TxPIS3eJQfxHXrT6iHC-9N5gX59u7zffS9u7q6ud9ubQgsqUlFrw6Qs29rWoha84o2xtillU7VCVKJlgjVSU1NRRgUXQm4sVLUlLduUGwqMX6Cvx9x5aQ6ryvWCHtQc3KjDXk3aqX9fvOtVNz0qSUUp5CHg0ykgTL8XiEnl3xoYBu1hWqJiguRelNM6S8uj1IQpxgDtyxhK1IGYysTUMzF1IpZtH_-u-GJ6RpQF5Cj4Y5-WkNce_5_5BNA0puU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2505361317</pqid></control><display><type>article</type><title>The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities</title><source>ACS Publications</source><creator>Robello, Marco ; Barresi, Elisabetta ; Baglini, Emma ; Salerno, Silvia ; Taliani, Sabrina ; Settimo, Federico Da</creator><creatorcontrib>Robello, Marco ; Barresi, Elisabetta ; Baglini, Emma ; Salerno, Silvia ; Taliani, Sabrina ; Settimo, Federico Da</creatorcontrib><description>Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast range of biological targets, thus presenting clinical potential for a plethora of pathological conditions. The purpose of this perspective is to provide insights into the versatility of this chemical moiety as a privileged structure in drug discovery. After a brief analysis of its physical–chemical features and synthetic procedures to obtain it, α-ketoamide-based classes of compounds are reported according to the application of this motif as either a nonreactive or reactive moiety. The goal is to highlight those aspects that may be useful to understanding the perspectives of employing the α-ketoamide moiety in the rational design of compounds able to interact with a specific target.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.0c01808</identifier><identifier>PMID: 33764065</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2021-04, Vol.64 (7), p.3508-3545</ispartof><rights>2021 The Authors. Published by American Chemical Society</rights><rights>2021 The Authors. Published by American Chemical Society 2021 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a515t-7ac2884f7d7575363bcddb48b6f5565f252b8a1c6121535589de67d0f29491e23</citedby><cites>FETCH-LOGICAL-a515t-7ac2884f7d7575363bcddb48b6f5565f252b8a1c6121535589de67d0f29491e23</cites><orcidid>0000-0002-9814-7195 ; 0000-0002-7897-7917 ; 0000-0002-5835-7796 ; 0000-0001-8675-939X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01808$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01808$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,776,780,881,2751,27055,27903,27904,56716,56766</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33764065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robello, Marco</creatorcontrib><creatorcontrib>Barresi, Elisabetta</creatorcontrib><creatorcontrib>Baglini, Emma</creatorcontrib><creatorcontrib>Salerno, Silvia</creatorcontrib><creatorcontrib>Taliani, Sabrina</creatorcontrib><creatorcontrib>Settimo, Federico Da</creatorcontrib><title>The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast range of biological targets, thus presenting clinical potential for a plethora of pathological conditions. The purpose of this perspective is to provide insights into the versatility of this chemical moiety as a privileged structure in drug discovery. After a brief analysis of its physical–chemical features and synthetic procedures to obtain it, α-ketoamide-based classes of compounds are reported according to the application of this motif as either a nonreactive or reactive moiety. The goal is to highlight those aspects that may be useful to understanding the perspectives of employing the α-ketoamide moiety in the rational design of compounds able to interact with a specific target.</description><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS0EotPCGyDkJZsM_okTDwuk0aiUilZlUdaWY98krhIn2E6left6mGkFG1aW7HPOPb4fQh8oWVPC6Gdt4vphBGt6GNfEECqJfIVWVDBSlJKUr9GKEMYKVjF-hs5jfCCEcMr4W3TGeV2VpBIrtNz3gLfD3Gv8A9KEt6OzgG8nB2mPdcQa_wzu0Q3Qgc3XybXYeXwL1hnn9YB3ebqLKey_4N0SAviEr310XZ-y11t8OULonO_w3TxPIS3eJQfxHXrT6iHC-9N5gX59u7zffS9u7q6ud9ubQgsqUlFrw6Qs29rWoha84o2xtillU7VCVKJlgjVSU1NRRgUXQm4sVLUlLduUGwqMX6Cvx9x5aQ6ryvWCHtQc3KjDXk3aqX9fvOtVNz0qSUUp5CHg0ykgTL8XiEnl3xoYBu1hWqJiguRelNM6S8uj1IQpxgDtyxhK1IGYysTUMzF1IpZtH_-u-GJ6RpQF5Cj4Y5-WkNce_5_5BNA0puU</recordid><startdate>20210408</startdate><enddate>20210408</enddate><creator>Robello, Marco</creator><creator>Barresi, Elisabetta</creator><creator>Baglini, Emma</creator><creator>Salerno, Silvia</creator><creator>Taliani, Sabrina</creator><creator>Settimo, Federico Da</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9814-7195</orcidid><orcidid>https://orcid.org/0000-0002-7897-7917</orcidid><orcidid>https://orcid.org/0000-0002-5835-7796</orcidid><orcidid>https://orcid.org/0000-0001-8675-939X</orcidid></search><sort><creationdate>20210408</creationdate><title>The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities</title><author>Robello, Marco ; Barresi, Elisabetta ; Baglini, Emma ; Salerno, Silvia ; Taliani, Sabrina ; Settimo, Federico Da</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a515t-7ac2884f7d7575363bcddb48b6f5565f252b8a1c6121535589de67d0f29491e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robello, Marco</creatorcontrib><creatorcontrib>Barresi, Elisabetta</creatorcontrib><creatorcontrib>Baglini, Emma</creatorcontrib><creatorcontrib>Salerno, Silvia</creatorcontrib><creatorcontrib>Taliani, Sabrina</creatorcontrib><creatorcontrib>Settimo, Federico Da</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robello, Marco</au><au>Barresi, Elisabetta</au><au>Baglini, Emma</au><au>Salerno, Silvia</au><au>Taliani, Sabrina</au><au>Settimo, Federico Da</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2021-04-08</date><risdate>2021</risdate><volume>64</volume><issue>7</issue><spage>3508</spage><epage>3545</epage><pages>3508-3545</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast range of biological targets, thus presenting clinical potential for a plethora of pathological conditions. The purpose of this perspective is to provide insights into the versatility of this chemical moiety as a privileged structure in drug discovery. After a brief analysis of its physical–chemical features and synthetic procedures to obtain it, α-ketoamide-based classes of compounds are reported according to the application of this motif as either a nonreactive or reactive moiety. The goal is to highlight those aspects that may be useful to understanding the perspectives of employing the α-ketoamide moiety in the rational design of compounds able to interact with a specific target.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>33764065</pmid><doi>10.1021/acs.jmedchem.0c01808</doi><tpages>38</tpages><orcidid>https://orcid.org/0000-0002-9814-7195</orcidid><orcidid>https://orcid.org/0000-0002-7897-7917</orcidid><orcidid>https://orcid.org/0000-0002-5835-7796</orcidid><orcidid>https://orcid.org/0000-0001-8675-939X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2021-04, Vol.64 (7), p.3508-3545
issn 0022-2623
1520-4804
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8154582
source ACS Publications
title The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T20%3A52%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Alpha%20Keto%20Amide%20Moiety%20as%20a%20Privileged%20Motif%20in%20Medicinal%20Chemistry:%20Current%20Insights%20and%20Emerging%20Opportunities&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Robello,%20Marco&rft.date=2021-04-08&rft.volume=64&rft.issue=7&rft.spage=3508&rft.epage=3545&rft.pages=3508-3545&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.0c01808&rft_dat=%3Cproquest_pubme%3E2505361317%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2505361317&rft_id=info:pmid/33764065&rfr_iscdi=true